UAE Transthyretin Amyloidosis Treatment Market Size & Outlook

The transthyretin amyloidosis treatment market in the UAE is expected to reach a projected revenue of US$ 2.6 million by 2030. A compound annual growth rate of 10.1% is expected of the UAE transthyretin amyloidosis treatment market from 2025 to 2030.
Revenue, 2024 (US$M)
$1.3
Forecast, 2030 (US$M)
$2.6
CAGR, 2025 - 2030
10.1%
Report Coverage
UAE

UAE transthyretin amyloidosis treatment market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UAE transthyretin amyloidosis treatment market, 2018-2030 (US$M)

Related Markets

UAE transthyretin amyloidosis treatment market highlights

  • The UAE transthyretin amyloidosis treatment market generated a revenue of USD 1.3 million in 2024 and is expected to reach USD 2.6 million by 2030.
  • The UAE market is expected to grow at a CAGR of 10.1% from 2025 to 2030.
  • In terms of segment, targeted therapy was the largest revenue generating therapy in 2024.
  • Targeted Therapy is the most lucrative therapy segment registering the fastest growth during the forecast period.

Transthyretin amyloidosis treatment market data book summary

Market revenue in 2024USD 1.3 million
Market revenue in 2030USD 2.6 million
Growth rate10.1% (CAGR from 2025 to 2030)
Largest segmentTargeted therapy
Fastest growing segmentTargeted Therapy
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTargeted Therapy, Supportive Therapy
Key market players worldwidePfizer Inc, Johnson & Johnson, Ionis Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc, BridgeBio Pharma Inc, Bristol-Myers Squibb Co, AstraZeneca PLC, Astellas Pharma Inc, Prothena Corp PLC, Acrotech BioPharma, SOM Biotech

Other key industry trends

  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, South Africa transthyretin amyloidosis treatment market is projected to lead the regional market in terms of revenue in 2030.
  • South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 115.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Transthyretin Amyloidosis Treatment Market Scope

Transthyretin amyloidosis treatment market segmentation & scope
Vyndaqel/ Vyndamax
Onpattro
Amvuttra
Tegsedi
Wainua
Supportive Therapy
Pipeline Therapy
ATTR with Polyneuropathy (ATTR-PN)
ATTR with Cardiomyopathy (ATTR-CM)
Polyneuropathy
Cardiomyopathy
Mixed Type
Wild Type Amyloidosis
Hospital Pharmacies
Specialty Pharmacies
Retail Pharmacies
Online Pharmacies

Transthyretin Amyloidosis Treatment Market Companies

Name Profile # Employees HQ Website

UAE transthyretin amyloidosis treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transthyretin amyloidosis treatment market will help companies and investors design strategic landscapes.


Targeted therapy was the largest segment with a revenue share of 107.69% in 2024. Horizon Databook has segmented the UAE transthyretin amyloidosis treatment market based on targeted therapy, supportive therapy covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to UAE transthyretin amyloidosis treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UAE transthyretin amyloidosis treatment market databook

  • Our clientele includes a mix of transthyretin amyloidosis treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UAE transthyretin amyloidosis treatment market , including forecasts for subscribers. This country databook contains high-level insights into UAE transthyretin amyloidosis treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UAE transthyretin amyloidosis treatment market size, by therapy, 2018-2030 (US$M)

UAE Transthyretin Amyloidosis Treatment Market Outlook Share, 2024 & 2030 (US$M)

UAE transthyretin amyloidosis treatment market size, by therapy, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more